These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 32453569)

  • 1. Structure-Permeability Relationship of Semipeptidic Macrocycles-Understanding and Optimizing Passive Permeability and Efflux Ratio.
    Le Roux A; Blaise É; Boudreault PL; Comeau C; Doucet A; Giarrusso M; Collin MP; Neubauer T; Kölling F; Göller AH; Seep L; Tshitenge DT; Wittwer M; Kullmann M; Hillisch A; Mittendorf J; Marsault E
    J Med Chem; 2020 Jul; 63(13):6774-6783. PubMed ID: 32453569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of the Passive Permeability of Semipeptidic Macrocycles: N- and C-Methylations Fine-Tune Conformation and Properties.
    Comeau C; Ries B; Stadelmann T; Tremblay J; Poulet S; Fröhlich U; Côté J; Boudreault PL; Derbali RM; Sarret P; Grandbois M; Leclair G; Riniker S; Marsault É
    J Med Chem; 2021 May; 64(9):5365-5383. PubMed ID: 33750117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beyond Rule-of-five: Permeability Assessment of Semipeptidic Macrocycles.
    L'Exact M; Comeau C; Bourhis A; Boisvert O; Fröhlich U; Létourneau D; Marsault É; Lavigne P; Grandbois M; Boudreault PL
    Biochim Biophys Acta Biomembr; 2023 Oct; 1865(7):184196. PubMed ID: 37400050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights on Structure-Passive Permeability Relationship in Pyrrole and Furan-Containing Macrocycles.
    Ly HM; Desgagné M; Nguyen DT; Comeau C; Froehlich U; Marsault É; Boudreault PL
    J Med Chem; 2024 Mar; 67(5):3711-3726. PubMed ID: 38417040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationships between structure and high-throughput screening permeability of peptide derivatives and related compounds with artificial membranes: application to prediction of Caco-2 cell permeability.
    Ano R; Kimura Y; Shima M; Matsuno R; Ueno T; Akamatsu M
    Bioorg Med Chem; 2004 Jan; 12(1):257-64. PubMed ID: 14697791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parallel artificial membrane permeability assay (PAMPA) combined with a 10-day multiscreen Caco-2 cell culture as a tool for assessing new drug candidates.
    Masungi C; Mensch J; Van Dijck A; Borremans C; Willems B; Mackie C; Noppe M; Brewster ME
    Pharmazie; 2008 Mar; 63(3):194-9. PubMed ID: 18444507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined application of parallel artificial membrane permeability assay and Caco-2 permeability assays in drug discovery.
    Kerns EH; Di L; Petusky S; Farris M; Ley R; Jupp P
    J Pharm Sci; 2004 Jun; 93(6):1440-53. PubMed ID: 15124203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural and conformational determinants of macrocycle cell permeability.
    Over B; Matsson P; Tyrchan C; Artursson P; Doak BC; Foley MA; Hilgendorf C; Johnston SE; Lee MD; Lewis RJ; McCarren P; Muncipinto G; Norinder U; Perry MW; Duvall JR; Kihlberg J
    Nat Chem Biol; 2016 Dec; 12(12):1065-1074. PubMed ID: 27748751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of various PAMPA models to identify the most discriminating method for the prediction of BBB permeability.
    Mensch J; Melis A; Mackie C; Verreck G; Brewster ME; Augustijns P
    Eur J Pharm Biopharm; 2010 Mar; 74(3):495-502. PubMed ID: 20067834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationships between structure and high-throughput screening permeability of diverse drugs with artificial membranes: application to prediction of Caco-2 cell permeability.
    Fujikawa M; Ano R; Nakao K; Shimizu R; Akamatsu M
    Bioorg Med Chem; 2005 Aug; 13(15):4721-32. PubMed ID: 15936203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantifying the chameleonic properties of macrocycles and other high-molecular-weight drugs.
    Whitty A; Zhong M; Viarengo L; Beglov D; Hall DR; Vajda S
    Drug Discov Today; 2016 May; 21(5):712-7. PubMed ID: 26891978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Passive Membrane Permeability of Macrocycles Can Be Controlled by Exocyclic Amide Bonds.
    Hickey JL; Zaretsky S; St Denis MA; Kumar Chakka S; Morshed MM; Scully CC; Roughton AL; Yudin AK
    J Med Chem; 2016 Jun; 59(11):5368-76. PubMed ID: 27120576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Property-Driven Development of Passively Permeable Macrocyclic Scaffolds Using Heterocycles.
    Saunders GJ; Yudin AK
    Angew Chem Int Ed Engl; 2022 Aug; 61(33):e202206866. PubMed ID: 35687524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enantiomeric cyclic peptides with different Caco-2 permeability suggest carrier-mediated transport.
    Marelli UK; Bezençon J; Puig E; Ernst B; Kessler H
    Chemistry; 2015 May; 21(22):8023-7. PubMed ID: 25917866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformational Effects on the Passive Membrane Permeability of Synthetic Macrocycles.
    Rzepiela AA; Viarengo-Baker LA; Tatarskii V; Kombarov R; Whitty A
    J Med Chem; 2022 Aug; 65(15):10300-10317. PubMed ID: 35861996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-Like Properties in Macrocycles above MW 1000: Backbone Rigidity versus Side-Chain Lipophilicity.
    Furukawa A; Schwochert J; Pye CR; Asano D; Edmondson QD; Turmon AC; Klein VG; Ono S; Okada O; Lokey RS
    Angew Chem Int Ed Engl; 2020 Nov; 59(48):21571-21577. PubMed ID: 32789999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parallel artificial membrane permeability assay (PAMPA) - Is it better than Caco-2 for human passive permeability prediction?
    Reis JM; Sinkó B; Serra CH
    Mini Rev Med Chem; 2010 Oct; 10(11):1071-6. PubMed ID: 21044031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In silico prediction of human oral absorption based on QSAR analyses of PAMPA permeability.
    Akamatsu M; Fujikawa M; Nakao K; Shimizu R
    Chem Biodivers; 2009 Nov; 6(11):1845-66. PubMed ID: 19937826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clearance-dependent underprediction of in vivo intrinsic clearance from human hepatocytes: comparison with permeabilities from artificial membrane (PAMPA) assay, in silico and caco-2 assay, for 65 drugs.
    Hallifax D; Turlizzi E; Zanelli U; Houston JB
    Eur J Pharm Sci; 2012 Apr; 45(5):570-4. PubMed ID: 22214813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between PAMPA permeability and cellular activities of hepatitis C virus protease inhibitors.
    Li C; Nair L; Liu T; Li F; Pichardo J; Agrawal S; Chase R; Tong X; Uss AS; Bogen S; Njoroge FG; Morrison RA; Cheng KC
    Biochem Pharmacol; 2008 Mar; 75(5):1186-97. PubMed ID: 18164692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.